Chronic disease program in Iran: Thalassemia control program

Ghobad Moradi, Ebrahim Ghaderi

DOI: 10.22122/cdj.v1i2.60


BACKGROUND: β-thalassemias (beta-thalassemia) is the most common genetic disorder; it is an inherited globinopathy which is transmitted to people due to a mutation in genes that create globin chain. In Iran, the disease gene is more common in the northern and southern regions. It is estimated that more than 60 mutations of the disease exist in different geographical areas of Iran. Iran has begun to adopt strategies to control the
β-thalassemia for two decades; the most important of which is the screening of couples when they want to get marry. The present study aimed to review the thalassemia control program in Iran, the history of the disease, and the disease control strategies.

METHODS: This review was conducted according to hand and electronic resources. Books, guidelines and document that exist in thalassemia control program were reviewed in the Iranian Ministry of Health, World Health Organization resources, PubMed, Google Scholar, SID (scientific information database), Magiran and, Iranmedex.

RESULTS: Thalassemia program was appropriately structured and has been achieved successes. Reduction the numbers of new cases of β-thalassemia were notably. In some areas, thalassemia program has some defects and the program faced some cultural barriers.

CONCLUSION: Due to the improvements in the social and economic situation of the people, it seems necessary to focus on prenatal diagnosis (PND) and pre-implantation genetic diagnosis (PNG) technique strategies and provide their necessary facilities.


Thalassemia, Surveillance, Epidemiology, Program, Iran

Full Text:



Miri-Moghaddam E, Naroienajad M, Eshghi P, Zeinali S, Savadkohi F. Molecular basis and prenatal diagnosis of beta-thalassemia among Balouch population in Iran. J Mazandaran Univ Med Sci 2005; 15(48): 111-5. [In Persian].

Thein SL. Dominant beta thalassaemia: molecular basis and pathophysiology. Br J Haematol 1992; 80(3): 273-7.

Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010; 5: 11.

Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Editor. The metabolic & molecular bases of inherited disease. 8th ed. Philadelphia, PA: McGraw-Hill; 2001. p. 14571-636.

Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, et al. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest 2005; 127(5): 1523-30.

Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003; 3(1): 4.

De S, V. Growth and puberty and its management in thalassaemia. Horm Res 2002; 58(Suppl 1): 72-9.

Borgna-Pignatti C, Cappellini MD, de Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y Acad Sci 2005; 1054: 40-7.

Weatherall DJ. Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci 2010; 1202: 17-23.

Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi MA. Causes of New Cases of Major Thalassemia in Sistan and Balouchistan Province in South-East of Iran. Iranian Journal of Public Health 2012; 41(11): 67-71. [In Persian].

Health deputy, disease control center. Comprehensive guideline and training material for national program of prevention of beta-thalassemia major. Tehran, Iran: Seda Publishing Center; 2004. [In Persian].

Habibzadeh F, Yadollahie M, Merat A, Haghshenas M. Thalassemia in Iran; an Overview. Arc Iranian Med 1998; 1: 27-33. [In Persian].

Nozari G, Rahbar S, Golshaiyzan A, Rahmanzadeh S. Molecular analyses of beta-thalassemia in Iran. Hemoglobin 1995; 19(6): 425-31.

Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007; 29(4): 233-8.

Akhlaghpoor S. Chorionic villus sampling for beta-thalassemia: the first report of experience in Iran. Prenat Diagn 2006; 26(12): 1131-6.

Fakher R, Keikhaei B, Aberumand M. Prenatal Diagnosis (PND) of β -Thalassemia in the Khuzestan Province, Iran. Journal of Clinical and Diagnostic Research 2007; 1(6): 454-9.

Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, Ghawidel-Parsa S, Naieni KH, Rahmani M, et al. Distribution of beta-thalassemia mutations in the northern provinces of Iran. Hemoglobin 2007; 31(3): 351-6.

Haghi M, Pouladi N, Hosseinpour Feizi M, Hosseinpour Feizi A. B-Thalassemia in Iran. JSSU 2010; 18(2): 127-33. [In Persian].

Najmabadi H, Ghamari A, Sahebjam F, Kariminejad R, Hadavi V, Khatibi T, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet 2006; 9(2): 93-7.

Merat A, Haghshenas M, Pour ZM, Plonczynski MW, Harrell AN, Coleman MB, et al. Beta-thalassemia in southwestern Iran. Hemoglobin 1993; 17(5): 427-37.

Cao A. Carrier screening and genetic counselling in beta-thalassemia. Int J Hematol 2002; 76 (Suppl 2): 105-13.

Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004; 329(7475): 1134-7.

Ministry of Health and Medical Education. Non-communicable disease data and statistics in Iran [Online]. [cited 2005]; Available from: URL: [In Persian].

Kuliev A, Rechitsky S, Verlinsky O, Ivakhnenko V, Evsikov S, Wolf G, et al. Preimplantation diagnosis of thalassemias. J Assist Reprod Genet 1998; 15(5): 219-25.

Dehshal MH, Ahmadvand A, Darestani SY, Manshadi M, Abolghasemi H. Secular trends in the national and provincial births of new thalassemia cases in Iran from 2001 to 2006. Hemoglobin 2013; 37(2): 124-37.

Cao A, Galanello R. Beta-thalassemia. Genet Med 2010; 12(2): 61-76.

Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: A retrospective analysis. Ann N Y Acad Sci 2005; 1054: 500-3.

Ahmed S, Green JM, Hewison J. Attitudes towards prenatal diagnosis and termination of pregnancy for thalassaemia in pregnant Pakistani women in the North of England. Prenat Diagn 2006; 26(3): 248-57.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 4.0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.